• CRIZANLIZUMAB chembl:CHEMBL4297734

    Alternate Names:

    SELG1
    SEG101
    SEG-101
    SEL-G1
    NVP-LXI-262
    CRIZANLIZUMAB
    NVP-LXI262

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications for treatment of sickle-cell disease
    (0 More Sources)

    Publications:

  • Interaction Score: 17.67

    Interaction Types & Directionality:
    antibody (inhibitory)
    inhibitor (inhibitory)

    Interaction Info:
    Trial Name SelG1
    Novel drug target Novel Target

    PMIDs:
    None found


    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications for treatment of sickle-cell disease
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

    • Version: 2020.06.01

    Alternate Names:
    D0A9ML TTD Drug ID

    Drug Info:

    Publications:

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: